Quantitative imaging of bromine-76 and yttrium-86 with PET: A method for removal of spurious activity introduced by cascade gamma rays

被引:61
作者
Beattie, BJ
Finn, RD
Rowland, DJ
Pentlow, KS
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Cyclotron Radiochem Core Facil, New York, NY 10021 USA
[5] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
关键词
D O I
10.1118/1.1595599
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Positron Emission Tomography of bromine-76 and yttrium-86 results in the detection of coincident events that are not strictly associated with annihilation photon pairs. Instead, these coincidences occur because prompt gamma rays emitted by these nuclides result in cascades of photons that are emitted within the timing window of the PET scanner. Pairs of detected photons from these cascades are not angularly correlated and therefore contain little information regarding the location of their source. Furthermore, these coincidences are not removed by correction procedures (e.g., randoms, scatter) routinely applied to PET data. If left uncorrected, the cascade coincidences will result in spurious apparent activity within the PET images. A correction, applied within projection space, that removes the cascade coincidence signal from septa-in (i.e., two-dimensional) datasets is proposed and tested on phantom data. (C) 2003 American Association of Physicists in Medicine.
引用
收藏
页码:2410 / 2423
页数:14
相关论文
共 24 条
[1]   Improved quantification for Tc-94m PET imaging [J].
Barker, WC ;
Szajek, LP ;
Green, SL ;
Carson, RE .
IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 2001, 48 (03) :739-742
[2]   CORRECTION FOR SCATTERED RADIATION IN A RING DETECTOR POSITRON CAMERA BY INTEGRAL TRANSFORMATION OF THE PROJECTIONS [J].
BERGSTROM, M ;
ERIKSSON, L ;
BOHM, C ;
BLOMQVIST, G ;
LITTON, J .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1983, 7 (01) :42-50
[3]   Use of 5-[76Br]bromo-2′-fIuoro-2′-deoxyuridine as a ligand for tumour proliferation:: validation in an animal tumour model [J].
Borbath, I ;
Grégoire, V ;
Bergström, M ;
Laryea, D ;
Långström, B ;
Pauwels, S .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2002, 29 (01) :19-27
[4]  
DEGRADO TR, 1994, J NUCL MED, V35, P1398
[5]  
Dupont S, 1999, J NUCL MED, V40, P935
[6]  
Finn RD, 1999, AIP CONF PROC, V475, P991
[7]   Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours:: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide [J].
Förster, GJ ;
Engelbach, M ;
Brockmann, J ;
Reber, H ;
Buchholz, HG ;
Mäcke, HR ;
Rösch, F ;
Herzog, H ;
Bartenstein, P .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) :1743-1750
[8]   [76Br]bromodeoxyuridine PET in tumor-bearing animals [J].
Gardelle, O ;
Roelcke, U ;
Vontobel, P ;
Crompton, NEA ;
Guenther, I ;
Bläuenstein, P ;
Schubiger, AP ;
Blattmann, H ;
Ryser, JE ;
Leenders, KL ;
Kaser-Hotz, B .
NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (01) :51-57
[9]   Monitoring interactions at ATP-dependent drug efflux pumps [J].
Hendrikse, NH .
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (16) :1653-1668
[10]   Optimized indirect 76Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET [J].
Höglund, J ;
Tolmachev, V ;
Orlova, A ;
Lundqvist, H ;
Sundin, A .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (08) :837-843